Merck is the first drug manufacturer to announce it is issuing refunds to 340B providers in 2024.
Merck Loosens 340B Contract Pharmacy Restrictions in Two States as Louisiana Law Takes Effect
Views
Drug manufacturer Merck recently loosened its 340B program contract pharmacy restrictions in Louisiana and Arkansas just before Louisiana’s law protecting [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.